Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine for Nocturia in Postmenopausal Women
NCT00323635Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in nocturia, sponsored by Brigham and Women's Hospital. Started Apr 2006; status: terminated.
02
Drugs
tolterodine
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT00323635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323635.